Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glabellar Lines”

155 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 155 results

Large-scale testing (Phase 3)Study completedNCT06124794
What this trial is testing

The Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Protox Inc. 155
Large-scale testing (Phase 3)Study completedNCT04247074
What this trial is testing

Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

Who this might be right for
Glabellar Frown Lines (GL)Lateral Canthal Lines (LCL)
Galderma R&D 413
Large-scale testing (Phase 3)Study completedNCT00512135
What this trial is testing

Safety and Efficacy of NT 201 (IncobotulinumtoxinA [Xeomin]) in the Treatment of Glabellar Frown Lines

Who this might be right for
Glabellar Lines
Merz Pharmaceuticals GmbH 801
Post-approval studies (Phase 4)Study completedNCT03687736
What this trial is testing

Subject Satisfaction With AbobutulinumtoxinA Treatment

Who this might be right for
Glabellar Frown Lines
Galderma R&D 120
Large-scale testing (Phase 3)Study completedNCT01797094
What this trial is testing

BOTOX® in the Treatment of Upper Facial Lines in Japan

Who this might be right for
Upper Facial RhytidesCrow's Feet LinesGlabellar Lines+1 more
Allergan 101
Very early researchUnknownNCT04715048
What this trial is testing

Split-Face Study Comparing Botox and Jeuveau in Treating Glabellar Lines

Who this might be right for
Glabellar Frown Lines
University of Southern California 20
Not applicableStudy completedNCT05517538
What this trial is testing

Split-face Study: Cosmetic Botulinum Toxin Type A Injection Under Electromyography-guidance Versus Conventional Palpation Technique

Who this might be right for
Glabellar Frown LinesRhytidesWrinkle+1 more
Mohamed Hayder Oleish Salih 15
Testing effectiveness (Phase 2)Study completedNCT04996810
What this trial is testing

The Safety and Efficacy Study of PROTOXIN in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Protox Inc. 60
Large-scale testing (Phase 3)Study completedNCT03732833
What this trial is testing

MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines

Who this might be right for
Lateral Canthal LinesGlabellar Lines
Medy-Tox 425
Large-scale testing (Phase 3)Study completedNCT02353871
What this trial is testing

Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
Ipsen 185
Early research (Phase 1)Study completedNCT06212960
What this trial is testing

Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Lines
Daewoong Pharmaceutical Co. LTD. 20
Large-scale testing (Phase 3)Study completedNCT00430963
What this trial is testing

IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
Merz Pharmaceuticals GmbH 256
Large-scale testing (Phase 3)Study completedNCT05380154
What this trial is testing

Efficacy and Safety Assessment of Botulax® and BOTOX® for Improvement of Glabellar Lines.

Who this might be right for
Glabellar Lines
Hugel 500
Large-scale testing (Phase 3)Study completedNCT01237977
What this trial is testing

Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar Lines

Who this might be right for
Skin Aging
Medy-Tox 314
Not applicableStudy completedNCT01808742
What this trial is testing

Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the CRYO-TOUCH III Device

Who this might be right for
Frown LinesGlabellar Frown Lines
Pacira Pharmaceuticals, Inc 17
Large-scale testing (Phase 3)Study completedNCT01189760
What this trial is testing

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines

Who this might be right for
Facial RhytidesCrow's Feet LinesGlabellar Lines
Allergan 917
Large-scale testing (Phase 3)Looking for participantsNCT06937944
What this trial is testing

Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
JHM BioPharma (Tonghua) Co. , Ltd. 669
Post-approval studies (Phase 4)UnknownNCT04281745
What this trial is testing

Long-term Open-label Treatment of Moderate to Severe Glabellar Lines With CORETOX®

Who this might be right for
Glabellar Frown Lines
Medy-Tox 200
Testing effectiveness (Phase 2)Study completedNCT05298449
What this trial is testing

Phase 2 of HU-045 in Glabellar Lines

Who this might be right for
Glabellar Lines
Huons Co., Ltd. 50
Large-scale testing (Phase 3)Study completedNCT03960957
What this trial is testing

Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Galderma R&D 301
Next Page